Evidence map›Paper›PMID 23184038›Full record

ArticleIntensive care medicine2013

Red blood cell transfusion in non-bleeding critically ill patients with moderate anemia: is there a benefit?

Santiago R Leal-Noval, Manuel Muñoz-Gómez, Mercedes Jiménez-Sánchez, Aurelio Cayuela, María Leal-Romero, Antonio Puppo-Moreno, Judy Enamorado, Victoria Arellano-Orden

Registry-linked trialOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Intensive care medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02461264 (Randomized Multicenter Trial of Two Transfusion Strategies for Patient Receiving Chemotherapy for Acute Leukemia or Hematopoietic Stem Cells With Medico-economic Evaluation of Cost Minimization.), which is not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02461264 phase3unknown statusnot on this mapstarted 2016, after this paper: background citation

Randomized Multicenter Trial of Two Transfusion Strategies for Patient Receiving Chemotherapy for Acute Leukemia or Hematopoietic Stem Cells With Medico-economic Evaluation of Cost Minimization.

TypeinterventionalSponsorUniversity Hospital, CaenRan2016 to 2019Enrolled230ConditionsTransfusion Related ComplicationArmsSingle red blood packed cells Transfusion, Two packed red blood cells Transfusion
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Transfusion, mortality and hemoglobin level: Associations among emergency department patients in Kigali, Rwanda.African journal of emergency medicine : Revue africaine de la medecine d'urgence · 2020
    Article
  10. Red blood cell transfusion policy: a critical literature review.Blood transfusion = Trasfusione del sangue · 2017
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Santiago R Leal-NovalCritical Care, Hospital Universitario Virgen del Rocío, Seville, Spain. srlealnoval@gmail.com
Manuel Muñoz-Gómez
Mercedes Jiménez-Sánchez
Aurelio Cayuela
María Leal-Romero
Antonio Puppo-Moreno
Judy Enamorado
Victoria Arellano-Orden
Hospital Universitario Virgen del Rocío · ESUniversidad de Málaga · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study was undertaken to investigate the efficacy of red blood cell transfusion (RBCT) at reversing the deleterious effects of moderate anemia in critically ill, non-bleeding patients.

methodsThis was a retrospective, pair-matched (ratio 1:1) cohort study. Non-bleeding critically ill patients with moderate anemia (nadir hemoglobin level between 70 and 95 g/l), admitted to the ICU over a 27-month period, were included. Anemic patients were included upon meeting five matching criteria of having the same nadir hemoglobin (±5 g/l), APACHE II score (±5), SOFA score (±2), admission diagnostic group, and age (±5 years). Outcome events occurring over the whole ICU stay and after RBCT were collected. After hospital discharge, all patients had a 2-year follow-up period.

resultsTwo hundred fourteen non-transfused anemic patients (NTAPs) were successfully matched with 214 transfused anemic patients (TAPs). In addition to the matching criteria, at baseline, both groups were homogenous with respect to multiple comorbidities. Compared with TAPs, NTAPs showed significantly lower rates of hospital mortality (21 vs.13 %, respectively; p < 0.05) and ICU re-admission (7.4 vs. 1.9 %, respectively; p < 0.05). Additionally, NTAPs had significantly lower rates of nosocomial infection (12.9 vs. 6.7 %, respectively; p < 0.05) and acute kidney injury (24.8 vs. 16.7 %, respectively; p < 0.05). Similar results were obtained in subgroup analysis where only more anemic patients (68 matched pairs) or patients with cardiovascular comorbidities (63 matched pairs) were considered.

conclusionsRBCT does not improve the clinical outcome in non-bleeding critically ill patients with moderate anemia.

Indexed as

Erythrocyte TransfusionAgedAnemiaCohort StudiesCritical IllnessFemaleHumansMaleMiddle AgedRetrospective StudiesSeverity of Illness Index

Identifiers

PMID23184038
OpenAlexW1966676758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.